Insider · CIK 0001184420

RUDNICK SETH

Reports to the SEC for 10 companies · WESTPORT, CT

sec.gov

Transactions

Companies

Filings

CIK

0001184420

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-29	G1 Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$22.35	−$223K	4,389
2021-06-29	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,031 sh	$0.30	+$609.3	14,389
2021-06-29	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,969 sh	—	—	0
2021-06-29	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,969 sh	$0.39	+$3,107.91	12,358
2021-06-29	G1 Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,031 sh	—	—	11,859
2021-06-17	G1 Therapeutics, Inc.A Award	Director	AAward	+4,389 sh	—	—	4,389
2021-06-17	G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+19.6K sh	—	—	19,620
2020-12-24	G1 Therapeutics, Inc.S Sale	Director	SSale	−924 sh	$20.10	−$18.6K	5,266
2020-12-23	G1 Therapeutics, Inc.S Sale	Director	SSale	−13.1K sh	$20.18	−$265K	6,190
2020-12-22	G1 Therapeutics, Inc.S Sale	Director	SSale	−19K sh	$20.33	−$386K	19,308
2020-12-10	G1 Therapeutics, Inc.S Sale	Director	SSale	−546 sh	$20.00	−$10.9K	38,282
2020-12-09	G1 Therapeutics, Inc.S Sale	Director	SSale	−5,773 sh	$20.32	−$117K	38,828
2020-12-08	G1 Therapeutics, Inc.S Sale	Director	SSale	−13.2K sh	$20.19	−$266K	44,601
2020-12-01	G1 Therapeutics, Inc.S Sale	Director	SSale	−520 sh	$20.09	−$10.4K	57,762
2020-06-22	Liquidia Technologies IncNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-11	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-08-29	Liquidia Technologies IncNonqualified Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2019-06-12	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-12-04	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,393 sh	$0.39	+$3,663.27	10,000
2018-12-04	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+607 sh	$0.39	+$236.73	607
2018-12-04	G1 Therapeutics, Inc.S Sale	Director	SSale	−9,884 sh	$39.31	−$389K	116
2018-12-04	G1 Therapeutics, Inc.S Sale	Director	SSale	−116 sh	$40.00	−$4,640	0
2018-12-04	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−607 sh	—	—	0
2018-12-04	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,393 sh	—	—	7,969
2018-11-05	G1 Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$41.53	−$415K	0
2018-11-05	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	607
2018-11-05	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$0.39	+$3,900	10,000
2018-10-04	G1 Therapeutics, Inc.S Sale	Director	SSale	−8,020 sh	$49.65	−$398K	1,980
2018-10-04	G1 Therapeutics, Inc.S Sale	Director	SSale	−1,980 sh	$49.99	−$99K	0
2018-10-04	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	10,607
2018-10-04	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$0.39	+$3,900	10,000
2018-09-04	G1 Therapeutics, Inc.S Sale	Director	SSale	−500 sh	$60.31	−$30.2K	0
2018-09-04	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	20,607
2018-09-04	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$0.39	+$3,900	10,000
2018-09-04	G1 Therapeutics, Inc.S Sale	Director	SSale	−9,500 sh	$59.93	−$569K	500
2018-08-06	G1 Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	30,607
2018-08-06	G1 Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$0.39	+$3,900	10,000
2018-08-06	G1 Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$50.69	−$507K	0
2018-06-07	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-07-11	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-05-22	G1 Therapeutics, Inc.C Conversion	Director	CConversion	+2,757 sh	—	—	58,282
2017-05-22	G1 Therapeutics, Inc.Series B Preferred StockC Conversion	Director	CConversion	−8,271 sh	—	—	0
2017-05-11	Old API Wind-down Ltd.A Award	Director	AAward	+7,500 sh	—	—	86,891
2017-05-11	Old API Wind-down Ltd.Director Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-03-15	Old API Wind-down Ltd.P Purchase	Director	PPurchase	+15K sh	$2.26	+$33.9K	79,391
2016-11-23	Old API Wind-down Ltd.G Gift	Director	GGift	+30K sh	—	—	30,000
2016-11-23	Old API Wind-down Ltd.G Gift	Director	GGift	−30K sh	—	—	64,391
2016-11-11	Old API Wind-down Ltd.P Purchase	Director	PPurchase	+30K sh	$4.77	+$143K	94,391
2016-06-16	Old API Wind-down Ltd.A Award	Director	AAward	+7,500 sh	—	—	64,391
2016-06-16	Old API Wind-down Ltd.Employee Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jun 304
RUDNICK SETH0001562180-21-004586
SEC(opens sec.gov)
Jun 214
RUDNICK SETH0001562180-21-004395
SEC(opens sec.gov)
Dec 294
RUDNICK SETH0001562180-20-007477
SEC(opens sec.gov)
Dec 234
RUDNICK SETH0001562180-20-007457
SEC(opens sec.gov)
Dec 104
RUDNICK SETH0001562180-20-007176
SEC(opens sec.gov)
Dec 34
RUDNICK SETH0001562180-20-007042
SEC(opens sec.gov)
Jun 234
RUDNICK SETH0001104659-20-076078
SEC(opens sec.gov)
Jun 124
RUDNICK SETH0001209191-20-036305
SEC(opens sec.gov)
Sep 34
RUDNICK SETH0001104659-19-048446
SEC(opens sec.gov)
Jun 144
RUDNICK SETH0001209191-19-037154
SEC(opens sec.gov)
Dec 44
RUDNICK SETH0001562180-18-004822
SEC(opens sec.gov)

Companies

Address

C/O CANAAN PARTNERS 285 RIVERSIDE AVENUE, SUITE 250

WESTPORT, CT, 06880